Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagel, H
Right arrow Articles by Schlott, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagel, H
Right arrow Articles by Schlott, T
Molecular Pathology 2003;56:226-231
© 2003 BMJ Publishing Group Ltd. & Association of Clinical Pathologists


ORIGINAL ARTICLE

Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands

H Nagel1, R Laskawi2, H Eiffert3 and T Schlott1

1 Department of Cytopathology, Georg-August-University of Göttingen, Robert-Koch-Straße 40, D-37075 Göttingen, Germany
2 Department of ENT, Georg-August-University of Göttingen
3 Department of Bacteriology, Georg-August-University of Göttingen

Correspondence to:
Dr H Nagel, Department of Cytopathology, Georg-August-University of Göttingen, Robert-Koch-Straße 40, D-37075 Göttingen, Germany;
hnagel{at}med.uni-goettingen.de

Aims: Molecular genetic changes involved in tumorigenesis and malignant transformation of human tumours are novel targets of cancer diagnosis and treatment. This study aimed to analyse the expression of putative tumour suppressor genes, FHIT and WT-1, and tumour rejection genes, BAGE, GAGE-1/2, MAGE-1, MAGE-3, and HAGE (which are reported to be important in human cancers), in salivary gland neoplasms.

Methods: Gene expression was analysed by reverse transcription polymerase chain reaction (RT-PCR) in normal salivary gland tissue and 44 benign and malignant salivary gland tumours.

Results: Aberrant FHIT transcripts were found in one of 38 normal salivary glands, three of 28 adenomas, and two of 16 carcinomas. WT-1 mRNA was detectable in two adenomas and five carcinomas. Immunoblotting showed that WT-1 mRNA expression was associated with raised WT-1 protein concentrations. RT-PCR for detection of BAGE, GAGE, and MAGE gene expression was positive in two adenomas and nine carcinomas, but negative in normal salivary gland tissue. HAGE mRNA was found in two normal salivary glands, 11 benign, and eight malignant tumours.

Conclusions: FHIT mRNA splicing does not appear to be involved in the genesis of salivary gland neoplasms. The upregulation of WT-1 mRNA in tumours of epithelial/myoepithelial phenotype may imply a potential role of WT-1 in the genesis and/or cellular differentiation of these salivary gland tumours. The tumour rejection genes were more frequently, but not exclusively, expressed in malignant salivary gland tumours than in benign neoplasms, although none was suitable as a diagnostic marker of malignancy in salivary gland neoplasms.


Keywords: salivary gland neoplasms; FHIT; WT-1; BAGE; GAGE; MAGE; HAGE

Abbreviations: FHIT, fragile histidine triad; RT-PCR, reverse transcription polymerase chain reaction; SCC, squamous cell carcinomas; SDS, sodium dodecyl sulfate; TBS, Tris buffered saline; WT-1, Wilms’s tumour suppressor gene 1







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.